Pawlikowski M, Lachowicz L, Kunert-Radek J, Winczyk K, Janiszewska G, Szkudlarek J
Department of Experimental Endocrinology, Institute of Endocrinology, Lodz, Poland.
Biochem Biophys Res Commun. 1998 May 19;246(2):375-7. doi: 10.1006/bbrc.1998.8624.
The effects of the native somatostatin-14 (SST-14) and of its analog octreotide (OCT) on the activity of protein tyrosine kinases (PTK) in the normal rat anterior pituitary gland, diethylstilbestrol (DES)-induced rat pituitary tumor and murine colonic cancer Colon 38 were studied in vitro. PTK activity was estimated in tissue homogenates using gamma-[32P]ATP and poly (Glu80, Tyr20) as a substrate. It was found that both SST-14 and OCT suppressed the PTK activity in all examined tissues. The suppressive effect was more pronounced in DES-induced pituitary tumor than in normal anterior pituitary gland, and in the former, OCT was more effective than SST-14. In contrast, SST-14 stronger suppressed PTK activity in colonic cancer than OCT. We hypothesize that SST-14 acts on PTK activity in colonic cancer mainly via SSTR-1 subtype of somatostatin receptors.
在体外研究了天然生长抑素-14(SST-14)及其类似物奥曲肽(OCT)对正常大鼠垂体前叶、己烯雌酚(DES)诱导的大鼠垂体肿瘤以及小鼠结肠癌Colon 38中蛋白酪氨酸激酶(PTK)活性的影响。使用γ-[32P]ATP和聚(Glu80,Tyr20)作为底物,在组织匀浆中估计PTK活性。发现SST-14和OCT均抑制所有检测组织中的PTK活性。在DES诱导的垂体肿瘤中,这种抑制作用比正常垂体前叶更明显,并且在前者中,OCT比SST-14更有效。相反,SST-14对结肠癌中PTK活性的抑制作用比OCT更强。我们推测SST-14主要通过生长抑素受体的SSTR-1亚型作用于结肠癌中的PTK活性。